Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Biogen’s Imraldi, an adalimumab biosimilar candidate referencing Humira, granted positive opinion by

cphi-onlineJune 27, 2017

Tag: Humira , biosimilar , Biogen

PharmaSources Customer Service